News
Roche Launches VENTANA BAP1 Test to Aid Mesothelioma Diagnosis
Roche strengthens cancer diagnostic portfolio with the launch of the VENTANA BAP1 (SP527) test for differential diagnosis of mesothelioma.
E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
Roche strengthens cancer diagnostic portfolio with the launch of the VENTANA BAP1 (SP527) test for differential diagnosis of mesothelioma.
HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
